221 related articles for article (PubMed ID: 18032916)
1. Feedback regulation of c-Myc by ribosomal protein L11.
Dai MS; Sears R; Lu H
Cell Cycle; 2007 Nov; 6(22):2735-41. PubMed ID: 18032916
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of c-Myc activity by ribosomal protein L11.
Dai MS; Arnold H; Sun XX; Sears R; Lu H
EMBO J; 2007 Jul; 26(14):3332-45. PubMed ID: 17599065
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal protein L11 associates with c-Myc at 5 S rRNA and tRNA genes and regulates their expression.
Dai MS; Sun XX; Lu H
J Biol Chem; 2010 Apr; 285(17):12587-94. PubMed ID: 20194507
[TBL] [Abstract][Full Text] [Related]
4. Ribosomal protein S14 negatively regulates c-Myc activity.
Zhou X; Hao Q; Liao JM; Liao P; Lu H
J Biol Chem; 2013 Jul; 288(30):21793-801. PubMed ID: 23775087
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation.
Li Y; Challagundla KB; Sun XX; Zhang Q; Dai MS
Oncotarget; 2015 Jan; 6(2):1101-14. PubMed ID: 25544755
[TBL] [Abstract][Full Text] [Related]
6. Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress.
Challagundla KB; Sun XX; Zhang X; DeVine T; Zhang Q; Sears RC; Dai MS
Mol Cell Biol; 2011 Oct; 31(19):4007-21. PubMed ID: 21807902
[TBL] [Abstract][Full Text] [Related]
7. Farnesiferol c induces apoptosis via regulation of L11 and c-Myc with combinational potential with anticancer drugs in non-small-cell lung cancers.
Jung JH; Kim MJ; Lee H; Lee J; Kim J; Lee HJ; Shin EA; Kim YH; Kim B; Shim BS; Kim SH
Sci Rep; 2016 May; 6():26844. PubMed ID: 27231235
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
Jung JH; Lee HJ; Kim JH; Sim DY; Im E; Kim S; Chang S; Kim SH
Cells; 2020 Apr; 9(4):. PubMed ID: 32316188
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex.
Liao JM; Zhou X; Gatignol A; Lu H
Oncogene; 2014 Oct; 33(41):4916-23. PubMed ID: 24141778
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer.
Dai MS; Lu H
J Cell Biochem; 2008 Oct; 105(3):670-7. PubMed ID: 18773413
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
Dai MS; Shi D; Jin Y; Sun XX; Zhang Y; Grossman SR; Lu H
J Biol Chem; 2006 Aug; 281(34):24304-13. PubMed ID: 16803902
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.
Dai MS; Lu H
J Biol Chem; 2004 Oct; 279(43):44475-82. PubMed ID: 15308643
[TBL] [Abstract][Full Text] [Related]
14. A positive feedback loop between EBP2 and c-Myc regulates rDNA transcription, cell proliferation, and tumorigenesis.
Liao P; Wang W; Shen M; Pan W; Zhang K; Wang R; Chen T; Chen Y; Chen H; Wang P
Cell Death Dis; 2014 Jan; 5(1):e1032. PubMed ID: 24481446
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
16. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway.
Horn HF; Vousden KH
Oncogene; 2008 Oct; 27(44):5774-84. PubMed ID: 18560357
[TBL] [Abstract][Full Text] [Related]
17. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.
Bhat KP; Itahana K; Jin A; Zhang Y
EMBO J; 2004 Jun; 23(12):2402-12. PubMed ID: 15152193
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.
Li L; Jin R; Zhang X; Lv F; Liu L; Liu D; Liu K; Li N; Chen D
Hepatology; 2012 Oct; 56(4):1380-90. PubMed ID: 22706665
[TBL] [Abstract][Full Text] [Related]
19. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop.
Ma F; Liu X; Zhou S; Li W; Liu C; Chadwick M; Qian C
Cancer Lett; 2019 May; 450():63-75. PubMed ID: 30771425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
